Cannabis Use Patterns Among Cancer Patients

Thomas Jefferson University

Status: Completed

Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm

Treatments: Other: Survey Administration

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT05132842

JT 16464 (Other Identifier)

21F.175

P30CA056036-21S3 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study determines patterns of cannabis use among cancer patients. Information collected in this study may help doctors to understand patient use of cannabis therapy, their knowledge and experiences with this therapy, benefits and risks associated with its use, and whether or to what extent they are discussing it with their health care providers.

Full description

PRIMARY OBJECTIVES:

I. To identify the frequency, modes, and duration of cannabis use, assess experiences with obtaining and using cannabis, as well as reasons for use and perceived risks and benefits of its use among cancer patients who are undergoing or have recently completed active treatment.

Ia. To uncover disparities in use of cannabis, perceptions of use, and communication with providers among cancer patients who are identify as racial and ethnic minorities, have low health or digital literacy, are of older age or low socioeconomic status.

II. Among cancer patients with a known medical marijuana certification, assess the impact of cannabis on pain management, anxiety, anorexia, and quality of life, as well as their communication with their oncology team about their procurement and use of cannabis.

OUTLINE:

Patients complete a survey about knowledge and awareness of medical cannabis, perceived risks and benefits of cannabis, mode and frequency of use (if applicable), impact on cancer-related symptoms, patient provider discussions about cannabis, and demographic characteristics including health and digital literacy.

Enrollment: 1,568 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Provide signed and dated informed consent form
• English speaking
• Willing to comply with all study procedures and be available for the duration of the study
• Any individual >= 18 years old
• At least one medical or radiation oncology appoint within the last 3 years at one of the SKCC cancer center campuses

Exclusion criteria

• Non-English speaking
• Not a cancer patient at one of the SKCC campuses
• Deceased

Trial design

1,568 participants in 1 patient group

Observational (survey)

Description:

Patients complete a survey about knowledge and awareness of medical cannabis, perceived risks and benefits of cannabis, mode and frequency of use (if applicable), impact on cancer-related symptoms, patient provider discussions about cannabis, and demographic characteristics including health and digital literacy.

Treatment:

Other: Survey Administration